Literature DB >> 4434088

Prolactin concentrations in patients with breast cancer.

S Franks, D N Ralphs, V Seagroatt, H S Jacobs.   

Abstract

Basal prolactin levels were measured before operation in 113 patients undergoing surgery for a lump in the breast. Prolactin concentrations were not significantly higher in those patients with breast cancer than in those with benign lumps. Prolactin concentrations were, however, found to be higher in premenopausal women than in postmenopausal ones, regardless of tumour histology.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4434088      PMCID: PMC1612938          DOI: 10.1136/bmj.4.5940.320

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  4 in total

Review 1.  Studies on prolactin in man.

Authors:  A G Frantz; D L Kleinberg; G L Noel
Journal:  Recent Prog Horm Res       Date:  1972

2.  Hypothalamic-pituitary-prolactin axis in breast cancer.

Authors:  I Mittra; J L Hayward; A S McNeilly
Journal:  Lancet       Date:  1974-05-11       Impact factor: 79.321

3.  Plasma prolactin in breast cancer.

Authors:  A R Boyns; E N Cole; K Griffiths; M M Roberts; R Buchan; R G Wilson; A P Forrest
Journal:  Eur J Cancer       Date:  1973-02       Impact factor: 9.162

4.  A homologous radioimmunoassay for human prolactin.

Authors:  Y N Sinha; F W Selby; U J Lewis; W P VanderLaan
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

  4 in total
  11 in total

1.  Prolactin concentrations during anaesthesia.

Authors:  L Morgan; A Barrett; F Beswick; T Hollway; P R Raggatt
Journal:  Br Med J       Date:  1976-10-23

Review 2.  Epidemiology and endocrinology of benign breast disease.

Authors:  D Y Wang; I S Fentiman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

3.  PRL, TSH, and thyroid hormones in benign breast diseases.

Authors:  F Peters; C R Pickardt; G Zimmermann; M Breckwoldt
Journal:  Klin Wochenschr       Date:  1981-04-15

4.  Treatment of benign breast disease with bromocriptine.

Authors:  A Mussa; L Dogliotti
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

5.  The effect of low dose carbidopa/levodopa on prolactin and growth hormone concentrations in patients with breast cancer and in benign breast tumours.

Authors:  M K Jones; I D Ramsay; P G Jenner
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

6.  Prolactin binding by human mammary carcinoma: relationship to estrogen receptor protein concentration and patient age.

Authors:  B Rae-Venter; T Nemoto; S L Schneider; T L Dao
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

Review 7.  Relation of the neuroendocrine system to the development and growth of experimental mammary tumors.

Authors:  J Meites
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

Review 8.  Prolactin and breast cancer etiology: an epidemiologic perspective.

Authors:  Shelley S Tworoger; Susan E Hankinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-02       Impact factor: 2.673

9.  Prolactin and total lactogenic hormone measured by microbioassay and immunoassay in breast cancer.

Authors:  P R Maddox; D L Jones; R E Mansel
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

10.  Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients.

Authors:  G Secreto; C Recchione; A Cavalleri; M Miraglia; V Dati
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.